Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Restructuring Costs (2024 - 2025)

TELA Bio (TELA) has 2 years of Restructuring Costs data on record, last reported at $2.1 million in Q3 2025.

  • For Q3 2025, Restructuring Costs rose 17.13% year-over-year to $2.1 million; the TTM value through Sep 2025 reached $8.0 million, changed N/A, while the annual FY2024 figure was $7.2 million, 0.66% up from the prior year.
  • Restructuring Costs reached $2.1 million in Q3 2025 per TELA's latest filing, down from $2.2 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $2.2 million in Q2 2025 and bottomed at $1.8 million in Q2 2024.